Possible pitfalls investigating cell death responses in genetically engineered mouse models and derived cell lines

Methods

Volumn 61, Issue 2, 2013, Pages 130-137

  Manzl, Claudia ^a   Baumgartner, Florian ^a   Peintner, Lukas ^a   Schuler, Fabian ^a   Villunger, Andreas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Apoptosis; Hematopoiesis; Lymphoma; Mouse models

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; EX VIVO STUDY; FEMALE; GENETIC ENGINEERING; HEMATOPOIESIS; HEMATOPOIETIC CELL; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; WHOLE BODY RADIATION;

ANIMALS; APOPTOSIS; ARTIFACTS; B-LYMPHOCYTE SUBSETS; BONE MARROW CELLS; CROSSES, GENETIC; DNA FRAGMENTATION; FEMALE; GRANULOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTE SUBSETS; WHOLE-BODY IRRADIATION;

ANIMALIA; MUS;

EID: 84879160862     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2013.02.012     Document Type: Article

References (33)

1. Tait S.W., Green D.R. Nat. Rev. Mol. Cell Biol. 2010, 11:621-632.
2. Kantari C., Walczak H. Biochim. Biophys. Acta 2011, 1813:558-563.
3. Kaufmann T., Strasser A., Jost P.J. Cell Death Diff. 2012, 19:42-50.
4. Los M., Wesselborg S., Schulze-Osthoff K. Immunity 1999, 10:629-639.
5. Zheng T.S., Hunot S., Kuida K., Flavell R.A. Cell Death Diff. 1999, 6:1043-1053.
6. Wang J., Lenardo M.J. J. Cell Sci. 2000, 113(Pt 5):753-757.
7. Kumar S. Cell Death Diff. 2007, 14:32-43.
8. Knudson C.M., Tung K.S., Tourtellotte W.G., Brown G.A., Korsmeyer S.J. Science 1995, 270:96-99.
9. Bouillet P., Metcalf D., Huang D.C., et al. Science 1999, 286:1735-1738.
10. Lindsten T., Ross A.J., King A., et al. Mol. Cell 2000, 6:1389-1399.
11. Labi V., Erlacher M., Kiessling S., et al. J. Exp. Med. 2008, 205:641-655.
12. Glaser S., Anastassiadis K., Stewart A.F. Nat. Gen. 2005, 37:1187-1193.
13. Kuida K., Zheng T.S., Na S., et al. Nature 1996, 384:368-372.
14. Woo M., Hakem R., Soengas M.S., et al. Genes Dev. 1998, 12:806-819.
15. Leonard J.R., Klocke B.J., D'Sa C., Flavell R.A., Roth K.A. J. Neuropathol. Exp. Neurol. 2002, 61:673-677.
16. Purdie C.A., Harrison D.J., Peter A., et al. Oncogene 1994, 9:603-609.
17. Armstrong J.F., Kaufman M.H., Harrison D.J., Clarke A.R. Curr. Biol. 1995, 5:931-936.
18. Chen X., Watkins R., Delot E., et al. Dev. Neurobiol. 2008, 68:265-273.
19. Sah V.P., Attardi L.D., Mulligan G.J., Williams B.O., Bronson R.T., Jacks T. Nat. gen. 1995, 10:175-180.
20. Ikeda S., Hawes N.L., Chang B., Avery C.S., Smith R.S., Nishina P.M. Invest. Ophthalmol. Vis. Sci. 1999, 40:1874-1878.
21. Ni H.M., Chen X., Chen L., DiFrancesca D., Harada H., Yin X.M. Apoptosis 2008, 13:53-62.
22. Kelly P.N., White M.J., Goschnick M.W., et al. Cell Death Diff. 2010, 17:1655-1664.
23. Baumgartner F., Woess C., Pedit V., Tzankov A., Labi V., Villunger A. Oncogene advance online publication March 2012, 19:1-10.
24. Bouillet P., Cory S., Zhang L.C., Strasser A., Adams J.M. Dev. cell 2001, 1:645-653.
25. Hughes P.D., Belz G.T., Fortner K.A., Budd R.C., Strasser A., Bouillet P. Immunity 2008, 28:197-205.
26. Frenzel A., Labi V., Chmelewskij W., et al. Blood 2010, 115:995-1005.
27. Kiselycznyk C., Holmes A. Front. Neurosci. 2011, 5:10.
28. Zurita E., Chagoyen M., Cantero M., et al. Transgenic Res. 2011, 20:481-489.
29. Meimaridou E., Kowalczyk J., Guasti L., et al. Nat. Gen. 2012, 44:740-742.
30. Mekada K., Abe K., Murakami A., et al. Experimental Animals/Japanese Association for Laboratory Animal Science 2009, 58:141-149.
31. Huang T.T., Naeemuddin M., Elchuri S., et al. Hum. Mol. Gen. 2006, 15:1187-1194.
32. Petkov P.M., Cassell M.A., Sargent E.E., et al. Genomics 2004, 83:902-911.
33. Manzl C., Krumschnabel G., Bock F., et al. J. Cell Biol. 2009, 185:291-303.